Top Markets
Coin of the day
Mabion S.A. Mabion S.A.

Mabion S.A.

MAB
株式のランク #26987
Mabion S.A. is a Polish biopharmaceutical firm dedicated to pioneering the... Mabion S.A. is a Polish biopharmaceutical firm dedicated to pioneering the development of biological drugs, primarily leveraging monoclonal antibody technology. The company oversees the full spectrum from research and development to the manufacturing and commercialization of therapies designed to combat a wide range of diseases, including neoplastic (cancer), autoimmune, metabolic, and neurological disorders. Key products in its portfolio include MabionCD20 and MabionHER2. Established in 2007, Mabion S.A. maintains its headquarters in Konstantynów Lódzki, Poland.
株価
$2.22
時価総額
$35.85M
変化(1日)
3.14%
変化(1年)
-15.06%
PL
取引 Mabion S.A. (MAB)

カテゴリー

Mabion S.A.(MAB)の配当利回りの履歴
Mabion S.A.(銘柄コード: MAB)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Mabion S.A.(MAB)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)